EXHIBIT 31.2


    CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, Michael A. Kramarz, Chief Financial Officer of Oncologix Tech, Inc. (the
"Company"), certify that:

(1)  I have reviewed this Annual Report on Form 10-KSB of the Company for the
     fiscal year ended August 31, 2007 (the "Report");

(2)  Based on my knowledge, the Report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary in order to make
     the statements made, in light of the circumstances under which such
     statements were made, not misleading with respect to the period covered by
     the Report;

(3)  Based on my knowledge, the financial statements, and other financial
     information included in the Report, fairly present in all material respects
     the financial condition and results of operations of the Company as of, and
     for, the periods represented in the Report;

(4)  The Company's other certifying officers and I are responsible for
     establishing and maintaining "disclosure controls and procedures" (as
     defined in Exchange Act Rules 13a-15(e) and 15d-15(e) for the Company and
     have:

     (a)  Designed such disclosure controls and procedures, or caused such
          disclosure controls and procedures to be designed under our
          supervision, to ensure that material information relating to the
          Company, including its consolidated subsidiaries, is made known to us
          by others with these entities, particularly during the period in which
          this Report is being prepared;

     (b)  Evaluated the effectiveness of the Company's disclosure controls and
          procedures and presented in this Report our conclusions about the
          effectiveness of the disclosure controls and procedures, as of the end
          of the period covered by this Report based on such evaluation; and

     (c)  Disclosed in this Report any change in the Company's internal control
          over financial reporting that occurred during the Company's most
          recent fiscal quarter (i.e., the fiscal year ended August 31, 2007)
          that has materially affected, or is reasonably likely to materially
          affect, the Company's internal control over financial reporting.

(5)  The Company's other certifying officers and I have disclosed, based on our
     most recent evaluation of internal control over financial reporting, to the
     Company's auditors and the audit committee of the Company's board of
     directors (or persons performing the equivalent functions):

     (a)  All significant deficiencies and material weaknesses in the design or
          operation of internal control over financial reporting which are
          reasonably likely to adversely affect the Company's ability to record,
          process, summarize and report financial information; and

     (b)  Any fraud, whether or not material, that involves management or other
          employees who have a significant role in the Company's internal
          control over financial reporting.

Dated:   December 14, 2007

By:  /s/  Michael A. Kramarz
   ------------------------------------
          Michael A. Kramarz
          Chief Financial Officer